Workflow
津药药业股份有限公司关于召开2024年度业绩说明会的公告

Core Viewpoint - The company plans to hold an investor briefing on May 16, 2025, to discuss its 2024 annual performance and financial results, allowing for interactive communication with investors [2][3]. Group 1: Meeting Details - The investor briefing is scheduled for May 16, 2025, from 13:00 to 14:45 [4]. - The meeting will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted via video live streaming and online interaction [4]. - Investors can participate by logging into the Roadshow Center during the specified time [4]. Group 2: Participation and Interaction - Investors can submit questions from May 9, 2025, to May 15, 2025, through the Roadshow Center's website or via the company's email [5]. - The company will address commonly asked questions during the briefing [5]. - Contact information for inquiries includes a designated contact person and email address [5]. Group 3: Attendees - Key attendees of the briefing will include the Chairman, General Manager, Independent Directors, Chief Financial Officer, and Board Secretary [4].